MAPT and Alzheimer disease: To further elucidate the effects of CAPON on AD pathology, we introduced CAPON cDNA into the brains of AppNL–G–F and AppNL–G–F X MAPT (hTau) double-KI mice using a newly developed adeno-associated virus (AAV)-mediated approach.